F. BAYRAM Et Al. , "Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG)," JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.3, pp.275-279, 2006
BAYRAM, F. Et Al. 2006. Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG). JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.3 , 275-279.
BAYRAM, F., TANRIVERDİ, F., KURTOĞLU, S., ATABEK, M. E., KULA, M., KAYNAR, L., ... Keleştimur, F.(2006). Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG). JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.3, 275-279.
BAYRAM, FAHRİ Et Al. "Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG)," JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.3, 275-279, 2006
BAYRAM, FAHRİ Et Al. "Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG)." JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.3, pp.275-279, 2006
BAYRAM, F. Et Al. (2006) . "Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG)." JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , vol.19, no.3, pp.275-279.
@article{article, author={FAHRİ BAYRAM Et Al. }, title={Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG)}, journal={JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM}, year=2006, pages={275-279} }